None listed
Conditions
Interventions
Medical Device : 1. gum level: No extra surgery by treating implants to show above the tissue.
- control: Straumann SLA tissue level
- experimental: Neobiotech IT-III Active
2. Bone level: Place impl
Sponsors
NeoBiotech
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? A person who has completed the growth of the bones between 19 and 75 years of age. ? Patients with premolars or molars defects on either side of the mandible ? Those who do not have severe incongruity between maxillary and mandibular relationships ? Those with sufficient vertical, buccal, and mesial-centered available bones ? A person who is sure of the patient motivation for implant treatment ? A person who agrees to participate in a clinical trial and signs a subject's consent form.
Exclusion criteria
Exclusion criteria: ? Pregnant women and the elderly and the weak who are unable to recover and operate ? A person with a history of cerebral infarction, cerebral hemorrhage, angina, and myocardial infarction ? A person who has an uncontrolled internal disease ? A person with an uncontrolled hemorrhagic disease ? A person suspected of mental illness or has a mental illness ? Those who have hypersensitivity to the implant material ? Those who have received radiation therapy, chemotherapy, or bone resorption inhibitory treatment ? Others who are inappropriate to participate in clinical trials as judged by the person in charge of clinical trials as they may affect the results of clinical trials ethically
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate(%) | — |
Secondary
| Measure | Time frame |
|---|---|
| Implant stability quotient;Alveolar bone loss;Difference in survival rate between tissue level and bone level (%);Periodontal examination (Furcation, Bleeding on Probing, Probing Depth);Implant stabillity test | — |
Countries
Korea, Republic of
Contacts
Public ContactJeongmin Ko
Korea University Anam Hospital
Outcome results
None listed